e09c4000ba03b832799e085b3a6f2d2b
Subscribe today
© 2025 The Bottom Line

Pacific Edge’s life on the ledge

4 min read

It was a major case of déjà vu – Pacific Edge’s share price was in freefall as the US administrator overseeing the Kiwi firm’s access to Obamacare coverage excluded the nifty Cxbladder non-invasive bladder detection tool alongside half a dozen other tests using biomarkers.

Cracking the US market has been an anchor of the firm’s plans for years, and it’s got further than many local com...


Top Stories
To read the full story, subscribe to The Bottom Line .
Click here to view our subscription options.